Skip to main content
Erschienen in: Hepatology International 1/2010

01.03.2010 | Original Article

Deep vein thrombosis in patients with advanced liver cirrhosis: a rare condition?

verfasst von: Cosmas Rinaldi A. Lesmana, Sri Inggriani, Lidwina Cahyadinata, Laurentius A. Lesmana

Erschienen in: Hepatology International | Ausgabe 1/2010

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Patients with liver cirrhosis are generally considered to be “auto-anticoagulated” because of coagulopathy and thrombocytopenia. However, deep vein thrombosis (DVT) has been reported in patients with liver cirrhosis. The objectives of this study were to know the prevalence of DVT among cirrhotic patients and to compare clinical pictures between cirrhotic patients with and without DVT.

Methods

A case–control study was performed on the basis of medical record data of patients with liver cirrhosis admitted between August 2004 and July 2007 in Medistra hospital in Jakarta. Diagnosis of DVT was established by duplex Doppler ultrasonography of the lower extremities. Patients with splanchnic thrombosis were excluded from this study. Diagnosis of liver cirrhosis was based on history and clinical manifestation, consistent with liver cirrhosis and confirmed by ultrasonography or computed tomography.

Results

A total of 256 patients with liver cirrhosis were included in this study; 164 (64.1%) among them were men. Patients’ mean age was 60.5 ± 12.5 years, ranging from 16 to 88 years. Viral hepatitis accounted for 74.6% of patients with liver cirrhosis. DVT was found in 12 (4.7%) patients. There was no significant laboratory difference between cirrhotic patients with and without DVT (serum albumin, platelet count, aminotransferases, γ-glutamyl transpeptidase, alkaline phosphatase, total bilirubin levels, and prothrombin time). Diabetes mellitus was significantly higher in the DVT group than that in the control group (66.6 vs. 34.0%, P = 0.025). Multivariate analysis confirmed diabetes mellitus as an independent risk factor for the occurrence of DVT (odds ratio = 4.26; 95% confidence interval = 1.206–15.034; P = 0.024).

Conclusions

The prevalence of DVT in patients with liver cirrhosis was 4.7%, and Deep vein thrombosis is not a rare condition in cirrhotic patients with coagulopathy and warrants further studies on the mechanisms and prevention.
Literatur
1.
Zurück zum Zitat Anderson FA, Spencer FA. Risk factors for venous thromboembolism. Circulation. 2003;107 Suppl I :9–16 Anderson FA, Spencer FA. Risk factors for venous thromboembolism. Circulation. 2003;107 Suppl I :9–16
2.
Zurück zum Zitat Alikhan R, Cohen AT, Combe S, et al. Risk factors for venous thromboembolism in hospitalized patients with acute medical illness: analysis of the MEDENOX Study. Arch Intern Med 2004;164:963–968CrossRefPubMed Alikhan R, Cohen AT, Combe S, et al. Risk factors for venous thromboembolism in hospitalized patients with acute medical illness: analysis of the MEDENOX Study. Arch Intern Med 2004;164:963–968CrossRefPubMed
3.
Zurück zum Zitat Zakai NA, Wright J, Cushman M. Risk factors for venous thrombosis in medical inpatients: validation of a thrombosis risk score. J Thromb Haemost 2004;2:2156–2161CrossRefPubMed Zakai NA, Wright J, Cushman M. Risk factors for venous thrombosis in medical inpatients: validation of a thrombosis risk score. J Thromb Haemost 2004;2:2156–2161CrossRefPubMed
4.
Zurück zum Zitat Bovill LG. Liver disease. In Goodnight SH, Hathaway WE, editors. Disorders of Haemostasis and Thrombosis, a Clinical Guide. New York: McGraw Hill; 2001. 226 Bovill LG. Liver disease. In Goodnight SH, Hathaway WE, editors. Disorders of Haemostasis and Thrombosis, a Clinical Guide. New York: McGraw Hill; 2001. 226
5.
Zurück zum Zitat Abeer Khalid AG, Gader A, Mohammed AG. The liver and the haemostatic system. Saudi J Gastroenterol 2003;9:59–68 Abeer Khalid AG, Gader A, Mohammed AG. The liver and the haemostatic system. Saudi J Gastroenterol 2003;9:59–68
6.
Zurück zum Zitat Northup PG, McMahon MM, Ruhl AP, Altschuler SE, Volk-Bednarz A, Caldwell SH. Coagulopathy does not fully protect hospitalized cirrhosis patients from peripheral venous thromboembolism. Am J Gastroenterol 2006;101:1524–1528CrossRefPubMed Northup PG, McMahon MM, Ruhl AP, Altschuler SE, Volk-Bednarz A, Caldwell SH. Coagulopathy does not fully protect hospitalized cirrhosis patients from peripheral venous thromboembolism. Am J Gastroenterol 2006;101:1524–1528CrossRefPubMed
7.
Zurück zum Zitat Senzolo M, Burra P, Cholongitas E, Burroughs AK. New insights into the coagulopathy of liver disease and liver transplantation. World J Gastroenterol 2006;12:7725–36PubMed Senzolo M, Burra P, Cholongitas E, Burroughs AK. New insights into the coagulopathy of liver disease and liver transplantation. World J Gastroenterol 2006;12:7725–36PubMed
8.
Zurück zum Zitat Caldwell SH, Hoffman M, Lisman T, Macik G, Northup PG, Reddy KR, et al. Coagulation disorders and hemostasis in liver disease: pathophysiology and critical assessment of current management. Hepatology. 2006;44:1039–1046CrossRefPubMed Caldwell SH, Hoffman M, Lisman T, Macik G, Northup PG, Reddy KR, et al. Coagulation disorders and hemostasis in liver disease: pathophysiology and critical assessment of current management. Hepatology. 2006;44:1039–1046CrossRefPubMed
9.
Zurück zum Zitat Protein C deficiency. In Goodnight SH, Hathaway WE, editors. Disorders of Haemostasis and Thrombosis, a Clinical Guide. New York: McGraw Hill; 2001. 369 Protein C deficiency. In Goodnight SH, Hathaway WE, editors. Disorders of Haemostasis and Thrombosis, a Clinical Guide. New York: McGraw Hill; 2001. 369
10.
11.
Zurück zum Zitat Petrauskiene V, Falk M, Waernbaum I, Norberg M, Eriksson JW. The risk of venous thromboembolism is markedly elevated in patients with diabetes. Diabetologia. 2005;48:1017–1021CrossRefPubMed Petrauskiene V, Falk M, Waernbaum I, Norberg M, Eriksson JW. The risk of venous thromboembolism is markedly elevated in patients with diabetes. Diabetologia. 2005;48:1017–1021CrossRefPubMed
12.
Zurück zum Zitat Ray JG, Lonn E, Yi Q, Rathe A, Sheridan P, Karon C, et al. Venous thromboembolism in association with features of the metabolic syndrome. Q J Med 2007;100:679–684 Ray JG, Lonn E, Yi Q, Rathe A, Sheridan P, Karon C, et al. Venous thromboembolism in association with features of the metabolic syndrome. Q J Med 2007;100:679–684
13.
Zurück zum Zitat Lee AYY. Management of thrombosis in cancer: primary prevention and secondary prophylaxis. Br J Haematol 2004;128:291–302CrossRef Lee AYY. Management of thrombosis in cancer: primary prevention and secondary prophylaxis. Br J Haematol 2004;128:291–302CrossRef
14.
Zurück zum Zitat Northup PG, Sundaram V, Fallon MB, Reddy KR, Balogun RA, Sanyal AJ, et al. Hypercoagulation and thrombophilia in liver disease. J Thromb Haemost 2008;6:2–9PubMed Northup PG, Sundaram V, Fallon MB, Reddy KR, Balogun RA, Sanyal AJ, et al. Hypercoagulation and thrombophilia in liver disease. J Thromb Haemost 2008;6:2–9PubMed
15.
Zurück zum Zitat Wells PS, Hirsh J, Anderson DR, Lensing AW, Foster G, Kearon C, et al. Accuracy of clinical assessment of deep-vein thrombosis. Lancet. 1995;345:1326–1330CrossRefPubMed Wells PS, Hirsh J, Anderson DR, Lensing AW, Foster G, Kearon C, et al. Accuracy of clinical assessment of deep-vein thrombosis. Lancet. 1995;345:1326–1330CrossRefPubMed
16.
Zurück zum Zitat Cushman M. Epidemiology and risk factors for venous thrombosis. Semin Hematol 2007;44:62–99CrossRefPubMed Cushman M. Epidemiology and risk factors for venous thrombosis. Semin Hematol 2007;44:62–99CrossRefPubMed
17.
Zurück zum Zitat Heit JA, Silverstein MD, Mohr DN, Petterson TM, O’Fallon WM, Melton LJ. Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case–control study. Arch Int Med 2000;160:809–815CrossRef Heit JA, Silverstein MD, Mohr DN, Petterson TM, O’Fallon WM, Melton LJ. Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case–control study. Arch Int Med 2000;160:809–815CrossRef
18.
Zurück zum Zitat White RH, Chew HK, Zhou H, Parikh-Patel A, Harris D, Harvey D, et al. Incidence of venous thromboembolism in the year before the diagnosis of cancer in 528, 693 adults. Arch Intern Med 2005;165:1782–1787CrossRefPubMed White RH, Chew HK, Zhou H, Parikh-Patel A, Harris D, Harvey D, et al. Incidence of venous thromboembolism in the year before the diagnosis of cancer in 528, 693 adults. Arch Intern Med 2005;165:1782–1787CrossRefPubMed
19.
Zurück zum Zitat Piccioli A, Aw Lensing, Prins MH, Falanga A, Scannapieco GL, Ieran M, et al. Extensive screening for occult malignant disease in idiopathic venous thromboembolism: a prospective randomized clinical trial. J Thromb Haemost 2004;2:884–889CrossRefPubMed Piccioli A, Aw Lensing, Prins MH, Falanga A, Scannapieco GL, Ieran M, et al. Extensive screening for occult malignant disease in idiopathic venous thromboembolism: a prospective randomized clinical trial. J Thromb Haemost 2004;2:884–889CrossRefPubMed
20.
Zurück zum Zitat Sørensen HT. Cancer and subsequent risk of venous thromboembolism. J Thromb Haemost 2006;4:527–528CrossRefPubMed Sørensen HT. Cancer and subsequent risk of venous thromboembolism. J Thromb Haemost 2006;4:527–528CrossRefPubMed
Metadaten
Titel
Deep vein thrombosis in patients with advanced liver cirrhosis: a rare condition?
verfasst von
Cosmas Rinaldi A. Lesmana
Sri Inggriani
Lidwina Cahyadinata
Laurentius A. Lesmana
Publikationsdatum
01.03.2010
Verlag
Springer-Verlag
Erschienen in
Hepatology International / Ausgabe 1/2010
Print ISSN: 1936-0533
Elektronische ISSN: 1936-0541
DOI
https://doi.org/10.1007/s12072-010-9166-6

Weitere Artikel der Ausgabe 1/2010

Hepatology International 1/2010 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Reizdarmsyndrom: Diäten wirksamer als Medikamente

29.04.2024 Reizdarmsyndrom Nachrichten

Bei Reizdarmsyndrom scheinen Diäten, wie etwa die FODMAP-arme oder die kohlenhydratreduzierte Ernährung, effektiver als eine medikamentöse Therapie zu sein. Das hat eine Studie aus Schweden ergeben, die die drei Therapieoptionen im direkten Vergleich analysierte.

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.